Wellington's first biotech-focused PE fund raises $393M

Wellington Management has closed its first private equity fund focused on drug discovery

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE